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Abstract 
 
Background  Exposures to indoor biological contaminants have been implicated in asthmas etiology but 
their effect on lung function is not well quantified.   
Objective  The aim of this cross-sectional study of non-smoking, asthmatic adults in Scotland was to 
determine the correlation between the results from a standard spirometry test, forced expiratory 
volume in one second percent (FEV1%), and quantitative estimates of some biological exposures. 
Methods  A population (n=55) of non-smoking, adult asthmatics in Scotland was included in a this study 
and each completed a questionnaire that allowed the determination of the Asthma Control 
Questionnaire scores (ACQ) and St. Georges Respiratory Questionnaire scores (SGRQ), as well as 
corticosteroid use.  Spirometry testing was completed and the pre-bronchodilator FEV1% value 
calculated.  At about the same time, floor dust samples were collected in the living room and in the 
bedroom.  These dust samples were analyzed for mold contamination, as described by the 
Environmental Relative Moldiness Index (ERMI) values and by (1, 3)-ɴ-D-glucan concentrations; and for 
endotoxin, and for dust mite, cat, and dog allergens concentrations.  The asthmatics FEV1% values were 
tested for correlation (Pearson) to questionnaire-based estimates of health.  Also, each biological 
exposure was tested for correlation (Pearson) to the FEV1% values.  
Results  FEV1% results were correlated with ACQ scores (rho -0.586, p<0.001), SGRQ scores (rho -0.313, 
p= 0.020), and weakly with corticosteroid use (rho -0.221, p= 0.105).  The ERMI values in the homes 
(average 5.3) was significantly correlated with FEV1% values (rho -0.378, p= 0.004). There was no 
correlation between FEV1% and concentrations of endotoxin, (1, 3)-ɴ-D-glucan, or any of the allergens.  
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Conclusion and clinical relevance  Although these results do not prove that mold exposures caused the 
deficit in lung function observed in this study, it might be advisable for asthmatics to avoid high ERMI 
environments.      
 
Keywords adults, asthma, FEV1%, ERMI, lung function  
 
Introduction 
Worldwide, 300 million people have asthma [1], including approximately 1.1 million children and 4.3 
million adults in the UK [2].  In Scotland, 1 in 14 people are currently receiving treatment for asthma.  
Surveys indicate that many patients with severe asthma have poor symptom control and reduced lung 
function [3, 4, 5].  Asthma has been associate with various biological exposures, including mold, 
endotoxin, and allergens (dust mite, insect, and animal).  Depending on the study, each of the agents 
has been reported to cause, have no effect on, or be protective of the asthma.  It is beyond the scope of 
this paper to review all of this literature.   However, only a few studies have examined these biological 
exposures and their association with lung function as quantified by spirometry testing and the resulting 
FEV1% values.        
   Mold exposures have often been estimated by using the cell product (1, 3)-ɴ-D-glucan.  The studies of 
(1, 3)-ɴ-D-glucans link to lung function generally report a lack of a relationship to FEV1% measurements.  
For example, Thorn and Rylander [6] found no effect of different exposures of 0 to 19 ng (1, 3)-ɴ-D-
glucan per m
3 
of air on FEV1%.  Similarly, Blanc et al. [7] found no correlation between (1, 3)-ɴ-D-glucan 
concentration in the dust and FEV1% values.  However, the high ERMI values in homes of asthmatic 
children in New Orleans was linked to reduced FEV1% values [8].    
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   Gram-negative bacterial exposures, estimated by measurement of endotoxin concentrations, were 
inversely associated with FEV1% values [7].  But in other studies, endotoxin exposures were found to be 
protective in a manner consistent with the hygiene hypothesis [9].  But high occupational levels of 
endotoxin caused FEV1% values to be reduced [10].  However, inhalation of 2 µg of endotoxin did not 
induce any changes in FEV1% values [11].  
 
     Dust mite allergen concentrations were not correlated with FEV1% values in a study of adult 
asthmatics in the U.S. [7].  Chiang et al. [12] also found no correlation between the concentration of 
dust mite allergen antibodies and lung function.  However, Omenaas et al. [13] found that exposure of 
dust mite allergen correlated with reduced FEV1% values in Norwegian adults.   These diverse findings 
might be explained by host genetics.  Abdelmotelb et al. [14] showed that the number of copies of the 
ɲ-tryptase gene might be critical to the effect of dust mite exposures on lung function.  
   The effect of exposures to insect and animal allergens on FEV1% values has been examined in some 
studies.  Weiss et al. [15] found that exposures to cockroach, but not dust mite or cat allergens, were 
correlated with a decline in FEV1% test results.  Jaén et al. [16] showed that exposure to cat allergen was 
associated with lower FEV1 values, but only for women. 
 
   The aims of this cross-sectional study of non-smoking, adult asthmatics in Scotland were to determine 
the correlation between FEV1% values and questionnaire-based measures of respiratory health and to 
determine the correlation between FEV1% values and some biological exposures in the home.  The dust 
samples and environmental and anonymous clinical data that were obtained in an earlier study [17] 
were utilized in this analysis.   
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Methods 
Study population 
The original study was approved by the Lanarkshire Research Ethics Committee and all participants gave 
written informed consent.  This study was conducted from 2006 to 2008 and the details have been 
published [17].  The original study design was to test whether an added home ventilation system might 
improve the respiratory health of asthmatic adults who were all allergic to house dust mites.  However, 
since dust samples were collected from each home and because spirometry testing was performed on 
each adult at baseline (before the intervention), there was an opportunity to use the baseline data and 
samples in a cross-sectional study of the effect of some biological exposures on the respiratory health of 
the asthmatic adults.   
 
   A volunteered smoking history was taken and serum samples obtained to determine the cotinine 
concentration (Cozart Bioscience Ltd, Abingdon, UK) in order to confirm smoking status [17].  Since 
smoking is the major exposure affecting pulmonary function [18], smokers were excluded from this 
evaluation of the relationship between biological exposures and respiratory health.   
 
   Persons 16 to 60 years of age with asthma were recruited for the original study [17].  At the time of 
the initial baseline clinical visit, a health questionnaire was completed and spirometry testing performed 
(before the use of a bronchodilator) by each person using a Vitalograph Spirometer (Buckingham, UK).  
The FEV1% of predicted normal was calculated using the European Community for Coal and Steel, 1993 
updated reference formula [19] which also adjusts for age, gender and height and is incorporated into 
the output from the spirometer.   
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Sampling  
At about the time of the clinical visit, dust samples were collected from the living room floor and 
separately from the bedroom floor of each home.  The open areas (not covered by lamps, 
furniture etc.) in each room were vacuumed at a rate of 1 m2 per min. using a Dyson, 1500 watt, 
model–DC 14 (Dyson, London, UK) vacuum cleaner [17].  For example, if there was 2 m2 of 
open floor space in a room, it was vacuumed for 2 min. to collect that sample.   
   The Dyson DC14 is a bagless vacuum cleaner that uses an extremely effective HEPA filter and 
captures all particles above 0.3 microns in size, as measured by a laser particle scanner The dust was 
collected in the vacuum’s reservoir which was meticulously cleaned between each sampling 
event.  The dust in the reservoir was emptied into a sealable bag, placed in a refrigerated cooler 
and returned to the laboratory.  At the laboratory, the dust samples were screened through a 2 
mm pore sieve to remove large particles and then stored at -20oC before further processing and 
analysis.  
 
Dust analysis  
The concentration of dust mite allergens, cat allergen, dog allergen, (1-3)-ɴ-glucan, and  endotoxin were 
quantified in each living room and bedroom sample, as previously described [17].  For the ERMI analysis, 
5.0 +/- 0.1 mg of the total, combined living room and bedroom dust samples was extracted using a 
bead-beater (after the internal reference organism was added), as previously described [20].   
   The 36 ERMI molds were quantified in each dust extract by QPCR analysis [20].  Briefly, the standard 
reaction assays contained 12.5 µl of Universal Master Mix (Applied Biosystems Inc., Foster City, CA), 1µl 
of a mixture of forward and reverse primers at 25 µM each, 2.5 µl of a 400 nM TaqMan probe (Applied 
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Biosystems Inc.), 2.5 µl of 2 mg/ml fraction V bovine serum albumin (Sigma Chemical, St. Louis, MO) and 
2.5 µl of DNA free water (Cepheid, Sunnyvale, CA).  To this mix was added 5 µl of the DNA extract from 
the sample.  All primer and probe sequences used in the assays have been published [21].  Primers and 
probes were synthesized commercially (Applied Biosystems, Inc.).  
   The ERMI value for each home was calculated, as shown in Eq. 1, by taking the Sum of the Logs of 
the concentrations of the 26 Group 1 species (s1) and subtracting the Sum of the Logs of the 
concentrations of 10 Group 2 species (s2) [22].
 
    
 
26 10
10 1 10 2
1 1
log ( ) log ( )i j
i j
ERMI s s
= =
= −¦ ¦  (Eq.1) 
(The 26 Group 1 species are found in water-damaged homes and the 10 Group 2 species are found 
in homes independent of water damage and that generally, but not exclusively, come from outdoors.)   
 
Statistical analyses  
Associations between FEV1% and other measures of respiratory health, i.e. ACQ, SGRQ scores and 
corticosteroid use, were determined via their respective Pearson correlation coefficients.  Likewise, 
relationship between FEV1% results and the biological exposures, i.e. ERMI values, allergens from dust 
mite, cat, and dog, (1, 3)-ɴ-D-glucan, and endotoxin, were determined via their respective Pearson 
correlation coefficients.  In addition, multiple linear-regression analysis was used to further investigate 
the relationship between FEV1% and the combination ERMI score and living room endotoxin levels, 
given the latters marginally significant relationship with FEV1%.  Regression analysis of FEV1% on ERMI 
was performed and graphed along with the corresponding 95% confidence interval.  Analyses were 
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performed in SAS version 9.3 (SAS Institute, Cary NC) and R version 2.14 (R Foundation for Statistical 
Computing, Vienna, Austria). 
 
Results  
The demographic, clinical or home characteristics of the non-smoking, adult asthmatics and their homes 
are shown in Table 1.  The FEV1% test results were correlated with ACQ scores 
(rho -0.586, p< 0.001), SGRQ scores (rho -0.313, p= 0.020), and weakly with corticosteroid use (rho -
0.221, p= 0.105) (Table 2).  The ERMI values in the homes were significantly correlated with FEV1% test 
results (rho -0.378, p= 0.004) (Table 3).  There was no correlation between FEV1% and the 
concentrations of endotoxin, (1, 3)-ɴ-D-glucan, or any of the allergens (Table 3).  
   The average ERMI value in these homes in Scotland was 5.3 (standard deviation 4.5) and the average 
FEV1% test result was 85.4% (standard deviation 18.6%).  The regression analysis scatter plot of FEV1% 
test results on ERMI values showed their inverse relationship (Fig. 1).  Living room endotoxin levels 
alone were marginally related to FEV1% values (p=0.063) and their inclusion in the multiple linear-
regression analysis, along with ERMI values, only increased the R
2
 of the regression from 14% to 17%.  
 
Discussion 
The demographic, clinical or home characteristics of the non-smoker, adult asthmatics and their homes 
are shown in Table 1.  Except for cotinine concentrations, these values were comparable to the entire 
cohort (smokers and non-smokers) in the original study (data not given) [17].  
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   We found that FEV1%, as an objective measure of respiratory health, was correlated with other 
measures of respiratory health which are based on recall in answering a questionnaire, i.e. 
corticosteroid use, ACQ and SGRQ scores.  The ACQ score does include the FEV1% value, so it is not 
surprising that the FEV1% values are the most highly correlated with ACQ scores.  The mold exposure, as 
described by the ERMI values in each home, was the only biological assessment that was correlated with 
FEV1% results.   
   The average ERMI value in these Scottish homes of asthmatic adults was 5.3.  In a study of asthmatic 
adults in the U.S., specifically California, the average ERMI value was 6.0 [23].  No other study of adult 
asthmatics has utilized the ERMI metric.  However, the homes of asthmatic children in three cities 
(Boston, Kansas City and San Diego) in the U.S., had an average ERMI value of 8.7 [24].  Also, infants 
exposed to homes with ERMI values above 5 were found to be twice as likely to develop asthma by age 
seven [25].  So the average ERMI value measured in the homes of asthmatic adults in Scotland was 
consistent with results from the homes of asthmatic adults and children in the US.        
 
   We recognize that asthma has a complex etiology and there are likely many causes.  However, if mold 
is causing some cases of asthma, then elucidating the agents causal mechanism would help clarify the 
relationship.   
   Recently, Millien et al [26] demonstrated that some molds can cause chronic airway surface mycotic 
infections (ASMI) in a mouse model of asthma.  These ASMI result in lung damage which includes 
enhanced airway epithelial and vascular endothelial cell permeability.  ASMI set into motion a cascade 
of events that led to asthma-like symptoms in these mice.  If this model is confirmed in humans, then it 
would help to explain why high mold exposures are linked to some cases of asthma.        
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   Many of the previous studies of the relationship between mold exposures and asthma have utilized 
methods that are not reliably quantified, e.g. visual inspection or moldy odor.  The ERMI is a 
standardized metric developed by the U.S. Environmental Protection Agency, in conjunction with the 
U.S. Department of Housing and Urban Development, to describe mold contamination in U.S. homes 
[22].  Its wider geographic applicability remains to be seen.   
   Although mold exposures have been linked to asthma in many studies [28, 29, 30], the linkage to lung 
function, as quantified by spirometry testing, has not often been included in such studies.  Norbäck et al. 
[2011] did show that the presence of dampness in homes was a risk factor for lung function decline, 
especially in women [31].  Although our results in Scotland suggest that there is a quantitative link 
between mold exposures and reduced lung function, this study cannot be considered as causal proof 
because of the studys many limitations.   
 
   The limitations of this study included the relatively small sample size, the fact that the sampled 
population was not randomly obtained (but part of earlier study), and many chemicals associated with 
decreased lung function [30, 31] were not measured.  Also, we did not quantify every possible biological 
exposure, including specific bacteria [32], viruses [33], or horse allergens [34] that might affect FEV1% 
values.  
   In addition, dust samples were used in this study, as opposed to air samples, which might have 
provided different results [35].  Also, we recognize that the ERMI scale was created for US housing and 
improvements to the scale might be made for Europe by a random European sampling of homes, as was 
done in the US to create the ERMI [36].   
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   In spite of these many limitations, this study in Scotland adds to the growing scientific literature linking 
mold exposure to poor respiratory health and asthma.  Therefore, it might be prudent for asthmatics to 
avoid high ERMI environments.      
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Table 1. Baseline demographic, clinical and home characteristics. 
Demographic Mean + Standard Deviation or % of total 
Age (years) 42 + 23
Gender (female) 65
Race (Caucasian) 98
Cotinine (ng/ml serum) 3.1 + 2.6
Clinical 
Duration of asthma (years) 20 + 13
Atopic dermatitis (positive) 15
Allergic hay fever (positive) 78
Allergic eczema (positive) 29
Dose of inhaled corticosteroid (µg)*  715 + 412
Home  
Age of home (years) 43 + 9.5
With carpets (positive)   85
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With cat (positive)   13
With dog (positive)    17
* Beclometasone equivalent  
 
Table2.  Pearson correlations of the forced expiratory volume in one second percent predicted (FEV1%) 
and other with other measures of respiratory health.  All spirometry tests were completed before use of 
a bronchodilator.  Abbreviations: IQR, interquartile range; ACQ, Asthma Control Questionnaire score; 
SGRQ, St. Georges Respiratory Questionnaire score. 
 Median (IQR) Pearsons rho p  value
FEV1% 88 (74, 99) 1.0 not applicable
ACQ score  1.4 (1.1, 2.4) -0.586 <0.001 
SGRQ score 27.3 (16.3, 39.6) -0.313 0.020 
Dose of inhaled corticosteroid (µg)* 800 (400, 1000) -0.221 0.105 
* Beclometasone equivalent  
 
 
Table 3. Pearson correlation between forced expiratory volume in one second percent predicted (FEV1%) 
and exposure variables (median).  Abbreviations: IQR, interquartile range; ERMI, Environmental Relative 
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Moldiness Index; Der p 1 and Der p 2, Dermatophagoides pteronyssinus allergens 1 and 2; Fel d 1, cat 
allergen; Can f 1, dog allergen; EU, endotoxin units.    
 Median (IQR) Pearsons rho p  value
ERMI 5.26 (2.6, 8.6) -0.378 0.004 
Living Room Der p 1 (ʅg/gm) 0.6 (0.2, 3.7) 0.006 0.967 
Living Room Der p 2 (ʅg/gm) 0.2 (0.1, 1.6) 0.045 0.755 
Living Room Fel d 1 (ʅg/gm) 0.4 (0.1, 1.6) -0.026 0.856 
Living Room Can f 1 (ʅg/gm) 4.6 (1.1, 27.5) -0.093 0.521 
Bedroom Der p 1 (ʅg/gm) 0.3 (1.0, 1.5) 0.017 0.910 
Bedroom Der p 2 (ʅg/gm) 0.2 (0.0, 1.9) 0.074 0.618 
Bedroom Fel d 1 (ʅg/gm) 0.4 (0.1, 5.8) -0.068 0.646 
Bedroom Can f 1 (ʅg/gm) 4.1 (0.5, 20.6) 0.016 0.911 
Living room endotoxin (EU/g dust) 10.4 (5.2, 16.7) -0.271 0.063 
Bedroom endotoxin (EU/g dust) 10.0 (5.2, 16.0) -0.204 0.169 
Living room glucan (ng/g dust) 435 (279, 631) -0.173 0.240 
Bedroom glucan (ng/g dust) 363 (277, 579) -0.107 0.472 
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Fig 1.  Scatter plot of Environmental Relative Moldiness Index (ERMI) values (n=55) and the  regression 
line (solid black) through the corresponding forced expiratory volume in one second percent predicted 
(FEV1%) values and the 95% confidence interval (dashed lines).  
 
